Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Factors in fish modifying methylmercury toxicity and metabolism.

Ganther HE, Sunde ML.

Biol Trace Elem Res. 2007 Dec;119(3):221-33.

PMID:
17916945
2.

Selenium compounds modulate the calcium release channel/ryanodine receptor of rabbit skeletal muscle by oxidizing functional thiols.

Xia R, Ganther HE, Egge A, Abramson JJ.

Biochem Pharmacol. 2004 Jun 1;67(11):2071-9.

PMID:
15135304
3.

New concepts in selenium chemoprevention.

Ip C, Dong Y, Ganther HE.

Cancer Metastasis Rev. 2002;21(3-4):281-9. Review.

PMID:
12549766
4.
5.
6.

Mechanisms of cell cycle arrest by methylseleninic acid.

Zhu Z, Jiang W, Ganther HE, Thompson HJ.

Cancer Res. 2002 Jan 1;62(1):156-64.

7.

Se-methylselenocysteine activates caspase-3 in mouse mammary epithelial tumor cells in vitro.

Unni E, Singh U, Ganther HE, Sinha R.

Biofactors. 2001;14(1-4):169-77.

PMID:
11568454
8.

Selenium metabolism and mechanisms of cancer prevention.

Ganther HE.

Adv Exp Med Biol. 2001;492:119-30. Review. No abstract available.

PMID:
11480661
9.

Selenotyrosine and related phenylalanine derivatives.

Ganther HE.

Bioorg Med Chem. 2001 Jun;9(6):1459-66.

PMID:
11408164
10.

Chemoprevention with triphenylselenonium chloride in selenium-deficient rats.

Ip C, Lisk DJ, Ganther HE.

Anticancer Res. 2000 Nov-Dec;20(6B):4179-82.

PMID:
11205245
11.

Methylseleninic acid, a potent growth inhibitor of synchronized mouse mammary epithelial tumor cells in vitro.

Sinha R, Unni E, Ganther HE, Medina D.

Biochem Pharmacol. 2001 Feb 1;61(3):311-7.

PMID:
11172735
12.
13.

Molecular mechanisms associated with Se-allylselenocysteine regulation of cell proliferation and apoptosis.

Jiang W, Zhu Z, Ganther HE, Ip C, Thompson HJ.

Cancer Lett. 2001 Jan 26;162(2):167-73.

PMID:
11146222
14.

In vitro effects of Se-allylselenocysteine and Se-propylselenocysteine on cell growth, DNA integrity, and apoptosis.

Zhu Z, Jiang W, Ganther HE, Ip C, Thompson HJ.

Biochem Pharmacol. 2000 Nov 15;60(10):1467-73.

PMID:
11020448
16.
17.

Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat.

Ip C, Zhu Z, Thompson HJ, Lisk D, Ganther HE.

Anticancer Res. 1999 Jul-Aug;19(4B):2875-80.

PMID:
10652567
18.
19.

Activities of structurally-related lipophilic selenium compounds as cancer chemopreventive agents.

Ip C, Lisk DJ, Ganther HE.

Anticancer Res. 1998 Nov-Dec;18(6A):4019-25.

PMID:
9891440
20.
21.

Differential induction of growth arrest inducible genes by selenium compounds.

Kaeck M, Lu J, Strange R, Ip C, Ganther HE, Thompson HJ.

Biochem Pharmacol. 1997 Apr 4;53(7):921-6.

PMID:
9174104
23.

Selenium deficiency and decreased coenzyme Q levels.

Vadhanavikit S, Ganther HE.

Mol Aspects Med. 1994;15 Suppl:s103-7.

PMID:
7752821
24.
25.
26.
27.

Decreased ubiquinone levels in tissues of rats deficient in selenium.

Vadhanavikit S, Ganther HE.

Biochem Biophys Res Commun. 1993 Feb 15;190(3):921-6.

PMID:
8439341
28.

Comparison of selenium and sulfur analogs in cancer prevention.

Ip C, Ganther HE.

Carcinogenesis. 1992 Jul;13(7):1167-70.

PMID:
1638682
29.

Effect of methylated forms of selenium on cell viability and the induction of DNA strand breakage.

Wilson AC, Thompson HJ, Schedin PJ, Gibson NW, Ganther HE.

Biochem Pharmacol. 1992 Mar 3;43(5):1137-41.

PMID:
1554385
30.
31.

Combination of blocking agents and suppressing agents in cancer prevention.

Ip C, Ganther HE.

Carcinogenesis. 1991 Feb;12(2):365-7.

PMID:
1899813
32.

Chemical form of selenium, critical metabolites, and cancer prevention.

Ip C, Hayes C, Budnick RM, Ganther HE.

Cancer Res. 1991 Jan 15;51(2):595-600.

33.

Activity of methylated forms of selenium in cancer prevention.

Ip C, Ganther HE.

Cancer Res. 1990 Feb 15;50(4):1206-11.

34.

Synergistic toxicity between arsenic and methylated selenium compounds.

Kraus RJ, Ganther HE.

Biol Trace Elem Res. 1989 Apr-May;20(1-2):105-13.

PMID:
2484390
35.

Chemical stability of selenious acid in total parenteral nutrition solutions containing ascorbic acid.

Ganther HE, Kraus RJ.

JPEN J Parenter Enteral Nutr. 1989 Mar-Apr;13(2):185-8.

PMID:
2496250
36.

Isolation of a novel rat testicular metalloprotein binding cadmium and zinc.

Kinoshita CM, Ganther HE.

Biol Trace Elem Res. 1988 Sep-Dec;17:189-206.

PMID:
2484358
37.

Nutritional availability and chronic toxicity of selenocyanate in the rat.

Vadhanavikit S, Ganther HE.

J Nutr. 1988 Jun;118(6):718-22.

PMID:
3373336
38.

Metabolism of selenocyanate in the rat.

Vadhanavikit S, Kraus RJ, Ganther HE.

Arch Biochem Biophys. 1987 Oct;258(1):1-6.

PMID:
3662536
39.

Hydrogen selenide and methylselenol.

Ganther HE, Kraus RJ.

Methods Enzymol. 1987;143:32-8. No abstract available.

PMID:
3657553
40.

Trimethylselenonium ion.

Ganther HE, Kraus RJ, Foster SJ.

Methods Enzymol. 1987;143:195-201. No abstract available.

PMID:
3309552
41.
42.

Formation of dimethyl selenide and trimethylselenonium from selenobetaine in the rat.

Foster SJ, Kraus RJ, Ganther HE.

Arch Biochem Biophys. 1986 May 15;247(1):12-9.

PMID:
3707137
43.

Analysis of trimethylselenonium ion in urine by high-performance liquid chromatography.

Kraus RJ, Foster SJ, Ganther HE.

Anal Biochem. 1985 Jun;147(2):432-6.

PMID:
4014687
44.
45.

Synthesis of [75Se]trimethylselenonium iodide from [75Se]selenocystine.

Foster SJ, Ganther HE.

Anal Biochem. 1984 Feb;137(1):205-9.

PMID:
6731798
46.

Identification of selenocysteine by high-performance liquid chromatography and mass spectrometry.

Ganther HE, Kraus RJ, Foster SJ.

Methods Enzymol. 1984;107:582-92. No abstract available.

PMID:
6239080
47.

Oxidation states of glutathione peroxidase.

Ganther HE, Kraus RJ.

Methods Enzymol. 1984;107:593-602. No abstract available.

PMID:
6094966
48.

Identification of selenocysteine in glutathione peroxidase by mass spectroscopy.

Kraus RJ, Foster SJ, Ganther HE.

Biochemistry. 1983 Dec 6;22(25):5853-8.

PMID:
6229276
49.
50.

Supplemental Content

Loading ...
Support Center